# Mesenchymal Stem Cell Infusion as Treatment for Steroid-Resistant Acute Graft Versus Host Disease (GVHD) or Poor Graft Function

> **NCT00603330** · PHASE2 · RECRUITING · sponsor: **University of Liege** · enrollment: 100 (estimated)

## Conditions studied

- Graft-versus-host Disease
- Poor Graft Function
- Low Donor T-cell Chimerism

## Interventions

- **BIOLOGICAL:** Mesenchymal stem cells

## Key facts

- **NCT ID:** NCT00603330
- **Lead sponsor:** University of Liege
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2008-01
- **Primary completion:** 2024-08
- **Final completion:** 2024-08
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2024-05-09

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00603330

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00603330, "Mesenchymal Stem Cell Infusion as Treatment for Steroid-Resistant Acute Graft Versus Host Disease (GVHD) or Poor Graft Function". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00603330. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*